American Century Companies’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Other funds holding XENE
ACA
PCH
DCM
JT
American Century Companies's XENE Position: Q2 2026 in Review
American Century Companies increased its Xenon Pharmaceuticals (XENE) stake by 30% in Q2 2026, buying an estimated $11.4M and bringing the position to 884,319 shares worth $53.4M. The position accounts for 0.02% of the portfolio, ranked #835.
American Century Companies first reported a position in XENE in Q3 2022 and has held it in 11 quarters since. 315 funds tracked by Wall St. Rank hold XENE as of Q2 2026.
- American Century Companies held 884,319 shares of Xenon Pharmaceuticals worth $53.4M as of Q2 2026.
- American Century Companies bought 205,005 Xenon Pharmaceuticals shares in Q2 2026, an estimated $11.4M.
- Xenon Pharmaceuticals made up 0.02% of American Century Companies's portfolio in Q2 2026, its #835 holding.
- American Century Companies first reported a position in Xenon Pharmaceuticals in Q3 2022 and has held it in 11 quarters since.
- 315 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.